Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system, including heart diseases and related health problems. They include arrhythmia detectors, noninvasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs, defibrillators and others.
Americas was the largest region in the cardiovascular devices market in 2016, accounting for over 47% of the market share. Asia was the second largest region accounting for around 25% of the market share. Europe was the third largest region accounting for over 20% of the market share.
Companies in the market are focusing on R&D. Areas of development include pacemakers, coronary stents, angioplasty products and implantable cardiac defibrillators. For instance, introduction of bio absorbable vascular stents in percutaneous coronary interventions is promising. In July 2016, the FDA approved the first fully absorbable stent, Absorb GT1 BVS manufactured by Abbott Vascular for coronary artery disease. It offers a new treatment option for patients undergoing angioplasty and opting for absorbable devices instead of metallic stents. In April 2016, FDA approved the world’s first leadless pacemaker, Micra Transcatheter Pacemaker System to treat heart rhythm disorders, which is manufactured by Medtronic Plc. This pacemaker can deliver percutaneously directly into the right ventricle through a minimally invasive approach, and does not require the use of wired leads in providing electrical connection between heart and pulse-generating devices.
Our reports have been used by over 10K customers, including:
Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Minimal Invasive Spinal Devices currently in pipeline stage. The report provides...
Increasing prevalence of CVD to drive the growth of this market. The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases;...
The Global Atherectomy Devices Market size is expected to reach $900.7 million by 2025, rising at a market growth of 6.8% CAGR during the forecast period (2019-2025). The atherectomy procedure has been recognized as a minimally invasive surgical technique to remove atherosclerosis from blood vessels in the human body. This surgical procedure...
The global spinal implant market is expected to reach more than $12 billion during the period 2018–2024. The gradual rise in spinal disorders, including lumbar spine stenosis, degenerative discs, disc herniation, and spinal stenosis among others, is one of the major contributing factors for the growth of the spinal implant market. The...
Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Hip Reconstruction Devices currently in pipeline stage. The report provides comprehensive...
Knee Reconstruction Devices - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Knee Reconstruction Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Knee Reconstruction Devices currently in pipeline stage. The report provides comprehensive...
Spinal Fusion Devices - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Spinal Fusion Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Spinal Fusion Devices currently in pipeline stage. The report provides comprehensive information...
Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019" provides an overview of Topical Absorbable Hemostats currently in pipeline stage. The report provides...
Market Overview Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated. According to the National Institute of Health, one in every 20 American, who is over...
The Europe mobile cardiac telemetry systems market is expected to reach US$ 477,845.5 Mn in 2027 from US$ 167,462.4 Mn in 2018. The market is estimated to grow with a CAGR of 13.0% from 2019-2027. The growth of the mobile cardiac telemetry systems market is primarily attributed to the rising prevalence of cardiovascular diseases and increasing...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.